Prospective Study on COVID -19 Reinfection on Vaccinated and Non-vaccinated Outpatients
NCT06544369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-08-09
Summary
the aim of the study is to compare the severity of symptoms in case of reinfection with COVID-19. the study will compare between two groups; vaccinated and non vaccinated. the side effects from vaccination and symptoms of infection and reinfection will be reprted.
Conditions
- COVID-19 Pandemic
Interventions
- BIOLOGICAL
-
COVID-19 vaccin
injection
Sponsors & Collaborators
-
Soad Ali
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-20
- Primary Completion
- 2022-01-18
- Completion
- 2022-01-18
Countries
- Egypt
Study Locations
More Related Trials
-
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults
NCT06237049 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age
NCT06694389 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus
NCT06851611 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
NCT01032395 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
NCT05519839 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine
NCT01465035 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
NCT05310084 ·Status: COMPLETED ·Phase: PHASE3
-
Covid-19 and Influenza Oral Vaccine Study
NCT06355232 ·Status: RECRUITING ·Phase: PHASE1
-
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom
NCT04583995 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Monitoring of BNT162b2 Second Vaccination Booster Effects in Health Care Workers (HCW)
NCT05516459 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
NCT06291857 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
NCT04961541 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine
NCT04508075 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
NCT04806529 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults
NCT05091307 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza
NCT05596734 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults
NCT06680375 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
NCT06683352 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.
NCT05858450 ·Status: COMPLETED
-
Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection
NCT05110911 ·Status: ACTIVE_NOT_RECRUITING
-
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
NCT05028361 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
NCT06821061 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine
NCT05107375 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines
NCT01111968 ·Status: COMPLETED ·Phase: PHASE1
-
Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines
NCT05095298 ·Status: UNKNOWN ·Phase: PHASE4